Polymorphism of the interleukin-10 gene in polycystic ovary syndrome

International Journal of Immunogenetics

Volumn 35, Issue 2, 2008, Pages 119-123

  Karadeniz, M ^a,b   Erdogan, M ^b   Zengi, A ^b   Tamsel, S ^b   Berdeli, A ^b   Saygili, F ^b   Yilmaz, C ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HORMONE; INSULIN; INTERLEUKIN 10; LIPID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ARTERY; CONTROL GROUP; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; VENOUS BLOOD;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CAROTID ARTERIES; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENE FREQUENCY; HUMANS; INFLAMMATION MEDIATORS; INSULIN; INTERLEUKIN-10; OBESITY; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNICA INTIMA;

EID: 40449093327     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2007.00746.x     Document Type: Article

References (26)

1. Aukrust, P., Yndestad, A., Waehre, T., Gullestad, L., Halvorsen, B. Damas, J.K. (2005) Inflammation in coronary artery disease: potential role for immunomodulatory therapy. Expert Review of Cardiovascular Therapy, 3, 1111.
2. Chambers, J.C. Kooner, J.S. (2001) Homocysteine: a novel risk factor for coronary heart disease in UK Indian Asians. Heart, 86 (2 121.
3. Chang, R.J. (2004) A practical approach to the diagnosis of polycystic ovary syndrome. American Journal of Obstetrics and Gynecology, 191 (3 713.
4. Donnelly, R.P., Dickensheets, H. Finbloom, D.S. (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. Journal of Interferon Cytokine Research, 19, 563.
5. Dunaif, A. (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews, 18, 774.
6. Dunaif, A., Segal, K., Futterweit, W. Dobrjansky, A. (1989) Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes, 38, 1165.
7. Fernandez-Real, J.M. Ricart, J. (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocrine Reviews, 24, 278.
8. Festa, A., D'Agostino Jr., R., Howard, G., Mykkanen, L., Tracy, R.P. Haffner, S.M. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation, 102, 42.
9. Fiorentiono, D.F., Zlotnik, A., Mosmann, T.R., Howard, M. O'Garra, A. (1991) IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology, 147, 3815.
10. Goodman-Gruen, D. Barrett-Connor, E. (2000) Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Diabetes Care, 23, 912.
11. Holte, J., Gennarelli, G., Wide, L. et al 1998) High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. Journal of Clinical Endocrinology and Metabolism, 83, 1143.
12. Kahraman, S., Yilmaz, R., Arici, M., Altun, B., Erdem, Y., Yasavul, U. Turgan, C. (2006) IL-10 genotype predicts serum levels of adhesion molecules, inflammation and atherosclerosis in hemodialysis patients. Nephrology, 19, 50.
13. Kelly, C.C., Lyall, H., Petrie, J.R., Gould, G.W., Connell, J.M. Sattar, N. (2001) Low grade chronic inflammation in women with polycystic ovarian syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 2453.
14. Larsson, H. Ahren, B. (1996) Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women. Diabetes Care, 19, 1399.
15. Lefer, A.M., Ma, X.L., Weyrich, A.S. Scalia, R. (1993) Mechanism of the cardioprotective effect of transforming growth factor beta 1 in feline myocardial ischemia and reperfusion. Proceedings of the National Academy of Sciences of the USA, 90, 1018.
16. Legro, R.S. (2003) Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocrine Reviews, 24, 302.
17. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412.
18. Oh, J.Y., Barrett-Connor, E., Wedick, N.M. et al 2002) Endogenous sex hormones and the development of type 2 diabetes in older men and women: The Rancho Bernardo Study. Diabetes Care, 25, 55.
19. Ridker, P.M., Buring, J.E., Shih, J., Matias, M. Hennekens, C.H. (1998) Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 98, 731.
20. Ridker, P.M., Hennekens, C.H., Buring, J.E. Rifai, N. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New England Journal of Medicine, 342, 836.
21. Scarpelli, D., Cardellini, M., Andreozzi, F., Laratta, E., Hribal, M.L., Marini, M.A., Tassi, V., Lauro, R., Perticone, F. Sesti, G. (2006) Variants of the interleukin-10 promoter gene are associated with obesity and insulin resistance but not type 2 diabetes in caucasian italian subjects. Diabetes, 55 (5 1529.
22. Schottelius, A.J.G., Mayo, M.W., Sartor, R.B. Baldwin, A.S. (1999) Interleukin-10 signaling blocks inhibitor of B kinase activity and nuclear factor B DNA binding. Journal of Biological Chemistry, 274, 318684.
23. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group 2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19 (1 41.
24. Turner, D.M., Williams, D.M., Sankaran, D., Lazarus, M., Sinnott, P.J. Hutchinson, I.V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. European Journal of Immunogenetics, 24, 1.
25. Van Exel, E., Gussekloo, J., De Craen, A.J., Frolich, M., Bootsma-Van Der Wiel, A. Westendorp, R.G. (2002) Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes: the Leiden 85-Plus Study. Diabetes, 51, 1088 Wolford, J.K. (2003) The interleukin-6 (-174) G/C promotor polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians. Human Genetics, 112, 409.
26. Wild, R.A. (1995) Obesity, lipids, cardiovascular risk, and androgen excess. American Journal of Medicine, 98, 27.